Concepedia

Author

Maili Zimmermann

University Medical Center Utrecht

Also Known As

M Zimmermann, M. Zimmermann, Maili Zimmermann, Zimmermann Maili

20

Publications

639

Citations

12

H-Index

31

Concepts

All Affiliations

University Medical Center UtrechtUtrecht UniversityMaasstad ZiekenhuisUniversity of VeronaUniversity of Milan
MZ

About

Maili Zimmermann is an author at University Medical Center Utrecht specializing in inflammation, medicine, and immune cell development.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

136

2

Cell Biology

2

2

136

3

Natural Sciences

1

1

65

4

Allergy

1

1

65

5

Cellular Physiology

1

1

71

Maili Zimmermann

×

9

Publications

473

Citations

9

H-Index

YearCitations

Chromatin remodelling and autocrine TNFα are required for optimal interleukin-6 expression in activated human neutrophils

Maili Zimmermann, Francisco Bianchetto Aguilera, Monica Castellucci,

Nature Communications

2015

93

IFNα enhances the production of IL-6 by human neutrophils activated via TLR8

Maili Zimmermann, Fábio Arruda-Silva, Francisco M. Bianchetto-Aguilera,

Scientific Reports

2016

85

CXCL4 drives fibrosis by promoting several key cellular and molecular processes

Alsya J. Affandi, Tiago Carvalheiro, Andrea Ottria,

Cell Reports

2022

71

Cutting Edge: An Inactive Chromatin Configuration at the IL-10 Locus in Human Neutrophils

Nicola Tamassia, Maili Zimmermann, Monica Castellucci,

The Journal of Immunology

2013

65

mTOR inhibition by metformin impacts monosodium urate crystal–induced inflammation and cell death in gout: a prelude to a new add-on therapy?

Nadia Vazirpanah, Andrea Ottria, Maarten van der Linden,

Annals of the Rheumatic Diseases

2019

65

Fatty Acid and Carnitine Metabolism Are Dysregulated in Systemic Sclerosis Patients

Andrea Ottria, A. Hoekstra, Maili Zimmermann,

Frontiers in Immunology

2020

35

Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren’s syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?

Sofie L. M. Blokland, Maarten R. Hillen, Catharina G. K. Wichers,

RMD Open

2019

22

Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2α

Andrea Ottria, Maili Zimmermann, Laurent M. Paardekooper,

Lara D. Veeken

2021

20

Angiopoietin-2 Promotes Inflammatory Activation in Monocytes of Systemic Sclerosis Patients

Tiago Carvalheiro, Ana P. Lopes, Maarten van der Kroef,

International Journal of Molecular Sciences

2020

17

Page 1